A vaccine under development at the University at Buffalo has demonstrated complete protection in mice against a deadly ...

BARYTHRAX, being the world's first recombinant protein anthrax vaccine, removed this risk and improved vaccine safety. BARYTHRAX has also improved vaccine stability by overcoming a key limitation ...

Traditional vaccines are made by attenuating Bacillus anthracis or culturing non-pathogenic Bacillus anthracis, which may contain residual toxin components. BARYTHRAX, being the world's first ...

The U.S. Centers for Disease Control and Prevention recommends that adults 50 and older receive two doses of the recombinant shingles vaccine, which includes an antigen that elicits an immune ...

The components in both inactivated and recombinant vaccines lack the biological machinery necessary to cause infection. First, the study remains in preprint status, meaning it has not completed ...

titers are significantly higher than those of currently marketed recombinant subunit control vaccines. Compared to similar products using the mRNA technology route, AIM's mRNA shingles vaccine ...

Though there are a few ways to make flu vaccines, including cell-based and recombinant vaccines, the most common method is to use chicken eggs to grow the virus strains. Egg-based vaccine ...

And shingrix is a recombinant vaccine (just a piece of the virus). So with a live attenuated, you’d still have the virus lurking in your nerve cells The risk of shingles after receiving the ...

It’s worth noting that this study focused on Zostavax, the older live-attenuated shingles vaccine, not the newer recombinant vaccine, Shingrix, which is now more widely used (and the vaccine ...